Dagco »

Plus Therapeutics shares owned by Dagco

Quarter-by-quarter ownership of Plus Therapeutics (PSTV) shares owned by Dagco from 13F filings

Historical chart of Dagco investment in Plus Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Plus Therapeutics held by Dagco consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Plus Therapeutics by Dagco

Quarter filed Position value Share count Share price at filing
2025-09-30 $18k 26k 0.68

More positions owned by Dagco

Ishares Tr Core Div Grwth (DGRO)
Spdr Ser Tr Portfolio Sh Tsr (SPTS)
Vanguard Index Fds Growth Etf (VUG)
Vanguard Whitehall Fds High Div Yld (VYM)
Ishares Tr Core S&p500 Etf (IVV)
Schwab Strategic Tr Us Lcap Gr Etf (SCHG)
Schwab Strategic Tr Us Dividend Eq (SCHD)
First Tr Exchange Traded Smid Risng Etf (SDVY)
Apple (AAPL)
Vanguard Specialized Funds Div App Etf (VIG)
Vanguard Whitehall Fds Intl Dvd Etf (VIGI)
Vanguard World Inf Tech Etf (VGT)
First Tr Exchng Traded Fd Vi Ft Vest Us Eqt (GJUL)
First Tr Exchange Traded Cap Strength Etf (FTCS)
Microsoft Corporation (MSFT)

View all positions for Dagco

Top funds holding Plus Therapeutics

Vanguard Group
Altium Capital Management
Geode Capital Management
UBS Group
BlackRock
State Street Corporation
Northern Trust
Scientech Research
Susquehanna International
Mercer Global Advisors
Dagco
Kestra Advisory Services
Cubist Systematic Strategies
Two Sigma Securities
Cambridge Investment Research Advisors

View all funds holding Plus Therapeutics